StockVS

纳斯达克 · USD

The Oncology Institute, Inc. (TOIIW) 股票分析

The Oncology Institute, Inc.(TOIIW)是在纳斯达克上市的股票,以美元交易。

TOIIW

$0.05

+$0.00 (+0.20%)

最后交易日2026年7月30日

这是一只衍生品——The Oncology Institute, Inc.(TOII)普通股的认股权证。

发行人的基本面数据显示在发行人页面,而非本页。

价格走势

悬停查看每日收盘价。虚线表示区间起始价。

TOIIW 关键统计数据

数据截至2026年7月30日
交易
开盘价
$0.18
前收盘价
$0.05
当日波动区间
0.05–0.05
52周波动区间
0.05–0.05
成交量
5
Beta系数股价相对大盘的波动幅度。1.0与大盘同步,高于1.0波动更大,低于1.0更小。
0.42

仅显示公司披露的指标。 数据由Yahoo Finance通过yfinance提供。每日更新。

TOIIW 历年回报率

历年回报率根据每日收盘价计算。 不完整年度以浅色显示并标有星号。

年份回报率
2026 (不完整年度)−74.21%
2025 (不完整年度)+0.00%

数据截至2026年7月30日。

最新新闻

新闻由第三方来源提供。不构成投资建议。

关于The Oncology Institute, Inc.

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

公司简介以英文显示。

访问官网 →